Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39


We do still transplant CML, don't we?

Craddock CF.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):177-184. doi: 10.1182/asheducation-2018.1.177. Review.


Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Tozatto-Maio K, Giannotti F, Labopin M, Ruggeri A, Volt F, Paviglianiti A, Kenzey C, Hayashi H, Cornelissen J, Michallet M, Karakasis D, Deconinck E, Rohrlich PS, de la Tour RP, Blaise D, Petersen E, D'Aveni M, Sengeloev H, Lamy T, Russell NH, Forcade E, Craddock CF, Nagler A, Gluckman E, Rocha V.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1657-1663. doi: 10.1016/j.bbmt.2018.02.014. Epub 2018 Mar 1.


Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.

Craddock CF, Houlton AE, Quek LS, Ferguson P, Gbandi E, Roberts C, Metzner M, Garcia-Martin N, Kennedy A, Hamblin A, Raghavan M, Nagra S, Dudley L, Wheatley K, McMullin MF, Pillai SP, Kelly RJ, Siddique S, Dennis M, Cavenagh JD, Vyas P.

Clin Cancer Res. 2017 Nov 1;23(21):6430-6440. doi: 10.1158/1078-0432.CCR-17-1423. Epub 2017 Aug 1.


Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT.

Burns DM, Rana S, Martin E, Nagra S, Ward J, Osman H, Bell AI, Moss P, Russell NH, Craddock CF, Fox CP, Chaganti S.

Bone Marrow Transplant. 2016 Jun;51(6):825-32. doi: 10.1038/bmt.2016.19. Epub 2016 Feb 22.


Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event.

Burns DM, Tierney R, Shannon-Lowe C, Croudace J, Inman C, Abbotts B, Nagra S, Fox CP, Chaganti S, Craddock CF, Moss P, Rickinson AB, Rowe M, Bell AI.

Blood. 2015 Dec 17;126(25):2665-75. doi: 10.1182/blood-2015-08-665000. Epub 2015 Oct 8.


Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening.

Lee JB, Billen A, Lown RN, Potter MN, Craddock CF, de Lavallade H, Shaw BE, Sharpe CC.

Bone Marrow Transplant. 2016 Feb;51(2):286-7. doi: 10.1038/bmt.2015.224. Epub 2015 Oct 5. No abstract available.


Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.

Brissot E, Labopin M, Beckers MM, Socié G, Rambaldi A, Volin L, Finke J, Lenhoff S, Kröger N, Ossenkoppele GJ, Craddock CF, Yakoub-Agha I, Gürman G, Russell NH, Aljurf M, Potter MN, Nagler A, Ottmann O, Cornelissen JJ, Esteve J, Mohty M.

Haematologica. 2015 Mar;100(3):392-9. doi: 10.3324/haematol.2014.116954. Epub 2014 Dec 19.


EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

Fox CP, Burns D, Parker AN, Peggs KS, Harvey CM, Natarajan S, Marks DI, Jackson B, Chakupurakal G, Dennis M, Lim Z, Cook G, Carpenter B, Pettitt AR, Mathew S, Connelly-Smith L, Yin JA, Viskaduraki M, Chakraverty R, Orchard K, Shaw BE, Byrne JL, Brookes C, Craddock CF, Chaganti S.

Bone Marrow Transplant. 2014 Feb;49(2):280-6. doi: 10.1038/bmt.2013.170. Epub 2013 Nov 11.


Effects of First-Grade Number Knowledge Tutoring With Contrasting Forms of Practice.

Fuchs LS, Geary DC, Compton DL, Fuchs D, Schatschneider C, Hamlett CL, Deselms J, Seethaler PM, Wilson J, Craddock CF, Bryant JD, Luther K, Changas P.

J Educ Psychol. 2013 Jan 1;105(1):58-77.


Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest.

Lown RN, Tulpule S, Russell NH, Craddock CF, Roest R, Madrigal JA, Shaw BE.

Haematologica. 2013 Dec;98(12):1956-63. doi: 10.3324/haematol.2013.088971. Epub 2013 Jun 28.


Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study.

Medd PG, Peniket AJ, Littlewood TJ, Pearce R, Perry J, Kirkland KE, Shaw BE, Potter MN, Craddock CF, Milligan DW, Fielding AK, Marks DI, Cook G; British Society of Blood and Marrow Transplantation.

Bone Marrow Transplant. 2013 Jul;48(7):982-7. doi: 10.1038/bmt.2012.261. Epub 2013 Jan 14. Erratum in: Bone Marrow Transplant. 2013 Oct;48(10):1368.


Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia.

Burnett AK, Russell NH, Hills RK, Kell J, Freeman S, Kjeldsen L, Hunter AE, Yin J, Craddock CF, Dufva IH, Wheatley K, Milligan D.

J Clin Oncol. 2012 Nov 10;30(32):3924-31. doi: 10.1200/JCO.2012.42.2964. Epub 2012 Jul 30.


Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).

Goodyear OC, Dennis M, Jilani NY, Loke J, Siddique S, Ryan G, Nunnick J, Khanum R, Raghavan M, Cook M, Snowden JA, Griffiths M, Russell N, Yin J, Crawley C, Cook G, Vyas P, Moss P, Malladi R, Craddock CF.

Blood. 2012 Apr 5;119(14):3361-9. doi: 10.1182/blood-2011-09-377044. Epub 2012 Jan 10.


Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML).

Murray JA, Khanim FL, Hayden RE, Craddock CF, Holyoake TL, Jackson N, Lumley M, Bunce CM, Drayson MT.

Br J Haematol. 2010 Apr;149(1):65-9. doi: 10.1111/j.1365-2141.2009.08055.x. Epub 2010 Jan 13.


Dynamic Assessment of Algebraic Learning in Predicting Third Graders' Development of Mathematical Problem Solving.

Fuchs LS, Compton DL, Fuchs D, Hollenbeck KN, Craddock CF, Hamlett CL.

J Educ Psychol. 2008 Nov;100(4):829-850.


Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms.

Shaw BE, Veys P, Pagliuca A, Addada J, Cook G, Craddock CF, Gennery AR, Goldman J, Mackinnon S, Madrigal JA, Marks DI, Navarrete C, Potter MN, Querol S, Regan F, Russell NH, Hough RE.

Bone Marrow Transplant. 2009 Jul;44(1):7-12. doi: 10.1038/bmt.2008.420. Epub 2009 Jan 12. Review.


Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.

Shaw BE, Mufti GJ, Mackinnon S, Cavenagh JD, Pearce RM, Towlson KE, Apperley JF, Chakraverty R, Craddock CF, Kazmi MA, Littlewood TJ, Milligan DW, Pagliuca A, Thomson KJ, Marks DI, Russell NH.

Bone Marrow Transplant. 2008 Dec;42(12):783-9. doi: 10.1038/bmt.2008.255. Epub 2008 Aug 25.


Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.

Craddock CF.

Bone Marrow Transplant. 2008 Mar;41(5):415-23. doi: 10.1038/sj.bmt.1705975. Epub 2008 Jan 21. Review.


Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia.

Olavarria E, Siddique S, Griffiths MJ, Avery S, Byrne JL, Piper KP, Lennard AL, Pallan L, Arrazi JM, Perz JB, O'Shea D, Goldman JM, Apperley JF, Craddock CF.

Blood. 2007 Dec 15;110(13):4614-7. Epub 2007 Sep 19.


Pertussis: should we vaccinate post transplant?

Kochethu G, Clark FJ, Craddock CF.

Bone Marrow Transplant. 2006 Apr;37(8):793-4. No abstract available.


The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia.

Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF, Moss PA, Briggs DC.

Blood. 2004 Feb 15;103(4):1521-6. Epub 2003 Sep 22.


Stem cell transplantation after salvage therapy with high-dose cytarabine and amsacrine in adults with high-risk leukaemia.

Tauro S, Shankaranarayana P, Nitu-Whalley IC, Duncan N, Begum G, Craig JI, Marcus RE, Craddock CF, Mahendra P.

Bone Marrow Transplant. 2003 Aug;32(3):273-8.


The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells.

Grimwade D, Outram SV, Flora R, Ings SJ, Pizzey AR, Morilla R, Craddock CF, Linch DC, Solomon E.

Cancer Res. 2002 Aug 15;62(16):4730-5.


Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion.

Lush RJ, Haynes AP, Byrne J, Cull GM, Carter GI, Pagliuca A, Parker JE, Mufti G, Mahendra P, Craddock CF, Lui Yin JA, Garg M, Prentice HG, Potter MN, Russell NH.

Cytotherapy. 2001;3(3):203-10.


Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice.

Craddock CF, Nakamoto B, Andrews RG, Priestley GV, Papayannopoulou T.

Blood. 1997 Dec 15;90(12):4779-88.


The role of CS1 moiety of fibronectin in VLA mediated haemopoietic progenitor trafficking.

Craddock CF, Nakamoto B, Elices M, Papayannopoulou Th.

Br J Haematol. 1997 Apr;97(1):15-21.


Chromosomal stabilisation by a subtelomeric rearrangement involving two closely related Alu elements.

Flint J, Rochette J, Craddock CF, Dodé C, Vignes B, Horsley SW, Kearney L, Buckle VJ, Ayyub H, Higgs DR.

Hum Mol Genet. 1996 Aug;5(8):1163-9.


Healing of broken human chromosomes by the addition of telomeric repeats.

Flint J, Craddock CF, Villegas A, Bentley DP, Williams HJ, Galanello R, Cao A, Wood WG, Ayyub H, Higgs DR.

Am J Hum Genet. 1994 Sep;55(3):505-12.


Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance.

Krishna S, Waller DW, ter Kuile F, Kwiatkowski D, Crawley J, Craddock CF, Nosten F, Chapman D, Brewster D, Holloway PA, et al.

Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):67-73.


Circulating stem cells in mice treated with cyclophosphamide.

Craddock CF, Apperley JF, Wright EG, Healy LE, Bennett CA, Evans M, Grimsley PG, Gordon MY.

Blood. 1992 Jul 1;80(1):264-9.


Cis-acting sequences regulating expression of the human alpha-globin cluster lie within constitutively open chromatin.

Vyas P, Vickers MA, Simmons DL, Ayyub H, Craddock CF, Higgs DR.

Cell. 1992 May 29;69(5):781-93.


Diurnal variation in serum cortisol concentrations in asthmatic subjects after allergen inhalation.

Durham SR, Keenan J, Cookson WO, Craddock CF, Benson MK.

Thorax. 1989 Jul;44(7):582-5.


Falls in peripheral eosinophil counts parallel the late asthmatic response.

Cookson WO, Craddock CF, Benson MK, Durham SR.

Am Rev Respir Dis. 1989 Feb;139(2):458-62.


Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses.

Durham SR, Craddock CF, Cookson WO, Benson MK.

J Allergy Clin Immunol. 1988 Nov;82(5 Pt 1):764-70.


Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.

Craddock CF, Richards NP, Powell RJ, Morgan AG.

Q J Med. 1987 Nov;65(247):895-8.


Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility.

Edwards R, Craddock CF, Russell T, Finch RG.

Lancet. 1986 Feb 8;1(8476):330-1. No abstract available.


Reversible coma in Wernicke's encephalopathy.

Rayner HC, Craddock CF.

Postgrad Med J. 1985 Dec;61(722):1097. No abstract available.

Supplemental Content

Loading ...
Support Center